购物车
- 全部删除
- 您的购物车当前为空
DA 3003-2为一种高效的选择性Cdc25抑制剂,展示了抗增殖活性,能诱导细胞周期在G2/M期停滞,并提高P-tyr15Cdc2表达量,显示出对前列腺癌研究的应用潜力。
DA 3003-2为一种高效的选择性Cdc25抑制剂,展示了抗增殖活性,能诱导细胞周期在G2/M期停滞,并提高P-tyr15Cdc2表达量,显示出对前列腺癌研究的应用潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,080 | 35日内发货 | |
5 mg | ¥ 4,720 | 35日内发货 | |
10 mg | ¥ 8,340 | 35日内发货 | |
25 mg | ¥ 16,800 | 35日内发货 |
产品描述 | DA 3003-2, a selectively potent Cdc25 inhibitor, exhibits antiproliferative activity and holds potential for prostate cancer research. It induces cell cycle arrest at the G2/M phase and increases the expression of P-tyr 15 Cdc2. |
体内活性 | Pentigetide (1 mg ; four times daily)-treated patients showed a statistically significant greater reduction in the frequency (P = .004) and severity (P = .05) of total nasal symptom score (sneezing, nasal congestion, and rhinorrhea) and in the individual nasal symptom scores compared with placebo-treated patients.[1] |
别名 | NSC663285 |
分子量 | 321.76 |
分子式 | C15H16ClN3O3 |
CAS No. | 383907-47-9 |
存储 | Shipping with blue ice. |
评论内容